cagrisema cagrilintide semaglutide phase 3 results 2024 2025 obesity REDEFINE 1 Trial Novo's Phase 3 CagriSema results – Cagrilintide–semaglutide (CagriSema) as an add-on – cagrisema semaglutide cagrilintide phase 3

...which increases insulin synthesis/release and suppresses glucagon production in a glucose-dependent manner Muscle Pancreas b cells a cells Insulin Glucagon Incretin enhancement can indirectly result in glucose uptake in peripheral tissues and a decrease in hepatic glucose production Liver Glucose GLP-1 (glucagon-like peptide-1) DPP-4 (dipeptidyl peptidase-4) JANUVIA GIP (glucose-dependent insulinotropic peptide) Important Information JANUVIA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

Discontinue use If Irritation or Itchiness occurs

(PubMed) Kucukgoncu S, Zhou E, Lucas KB, Tek C

Suggested Use / Directions: As a dietary supplement, take one capsule per day, or as directed by your health care practitioner

Banerjee SS, Feinberg MW, Watanabe M, Gray S, Haspel RL, Denkinger DJ, et al

In the first 24 to 48 hours, many patients notice subtle changes in appetite and satiety